Early research (Phase 1)UnknownNCT03015922What this trial is testingViral Immunotherapy in Relapsed/Refractory Multiple MyelomaWho this might be right forMultiple Myeloma University of Leeds 4
Large-scale testing (Phase 3)Ended earlyNCT03440411What this trial is testingPom-dex Versus Pom-Cyclo-dex in MM Patients With Biochemical or Clinical Relapse, During Lena Maintenance TreatmentWho this might be right forMultiple Myeloma Fondazione EMN Italy Onlus 9
Testing effectiveness (Phase 2)Study completedNCT03910244What this trial is testingPomalidomide for the Treatment of Bleeding in HHTWho this might be right forTelangiectasia, Hereditary Hemorrhagic The Cleveland Clinic 145
Not applicableNot Yet RecruitingNCT07015021What this trial is testingThe Efficacy and Safety of the Combination Therapy of Daratumumab, Cabozantinib, Pomalidomide, and Dexamethasone (D-KPd) in the Treatment of High-risk First-time Relapsed or Primary Refractory MM PatientsWho this might be right forMultiple MyelomaCarfilzomibDaratumumab+1 more The First Affiliated Hospital of Soochow University 72
Testing effectiveness (Phase 2)Study completedNCT02963493What this trial is testingMelphalan Flufenamide (Melflufen) Plus Dexamethasone in Patients With Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Oncopeptides AB 157
Testing effectiveness (Phase 2)Ended earlyNCT04243109What this trial is testingStudy of Pomalidomide, Oral Dexamethasone and Very Low-dose Cyclophosphamide in Patients With Refractory Multiple Myeloma Who Have Received Lenalidomide and BortezomibWho this might be right forMultiple Myeloma Maimónides Biomedical Research Institute of Córdoba 6
Testing effectiveness (Phase 2)Ended earlyNCT01946152What this trial is testingPomalidomide, Dexamethasone, and Filgrastim-sndz in Treating Patients With Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma-Light Chain OnlyRecurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma M.D. Anderson Cancer Center 21
Large-scale testing (Phase 3)Looking for participantsNCT06561854What this trial is testingStudy Comparing Therapy for Advanced Relapsed/Refractory Multiple Myeloma With and Without DexamethasoneWho this might be right forMultiple MyelomaRelapse Multiple Myeloma Assistance Publique - Hôpitaux de Paris 318
Large-scale testing (Phase 3)Study completedNCT01178281What this trial is testingStudy of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-DependenceWho this might be right forPrimary MyelofibrosisMPN-associated Myelofibrosis Celgene 267
Early research (Phase 1)Ended earlyNCT01078974What this trial is testingPomalidomide, Dexamethasone and Rituximab in Waldenstrom's MacroglobulinemiaWho this might be right forWaldenstrom's Macroglobulinemia Steven P. Treon, MD, PhD 7
Large-scale testing (Phase 3)UnknownNCT03143049What this trial is testingPomalidomide-Cyclophosphamide-Dexamethasone (PCD) Versus Pomalidomide-Dexamethasone (PD) in Relapse or Refractory MyelomaWho this might be right forRelapse Multiple Myeloma National University Hospital, Singapore 120
Post-approval studies (Phase 4)UnknownNCT04989140What this trial is testingStudy of Pomalidomide, Oral Dexamethasone and Ixazomib in Patients With Relapsed MM Who Have Received LenalidomideWho this might be right forMultiple Myeloma Peking Union Medical College Hospital 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT04764942What this trial is testingSelinexor, Pomalidomide, and Dexamethasone With or Without Carfilzomib for the Treatment of Patients With Relapsed Refractory Multiple Myeloma, The SCOPE TrialWho this might be right forRecurrent Multiple MyelomaRefractory Multiple Myeloma Mayo Clinic 39
Testing effectiveness (Phase 2)UnknownNCT03113942What this trial is testingStudy of Pomalidomide in Anal Cancer PrecursorsWho this might be right forHigh Grade Squamous Intra-epithelial Lesion (HSIL) Kirby Institute 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT02542657What this trial is testingIxazomib with Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients with Multiple MyelomaWho this might be right forMyeloma Joseph Tuscano 30
Testing effectiveness (Phase 2)Study completedNCT01432600What this trial is testingPomalidomide in Combination With High Dose Dexamethasone and Oral CyclophosphamideWho this might be right forMyeloma H. Lee Moffitt Cancer Center and Research Institute 80
Testing effectiveness (Phase 2)Study completedNCT03731832What this trial is testingPomalidomide, Ixazomib, and Dexamethasone With or Without Intensification by Cyclophosphamide in Relapsed or Refractory Multiple MyelomaWho this might be right forRefractory Multiple Myeloma GWT-TUD GmbH 66
Large-scale testing (Phase 3)Study completedNCT01734928What this trial is testingSafety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in Subjects With Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Celgene 559
Testing effectiveness (Phase 2)UnknownNCT02004275What this trial is testingPomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple MyelomaWho this might be right forMultiple Myeloma in Relapse Alliance for Clinical Trials in Oncology 118
Post-approval studies (Phase 4)Study completedNCT05555329What this trial is testingAlternative Dosing Scheme of Pomalidomide 4 mg Every Other Day Versus Pomalidomide 2 mg and 4 mg Every Day; the POMAlternative StudyWho this might be right forMultiple Myeloma in RelapseMultiple MyelomaMultiple Myeloma, Refractory Amsterdam UMC, location VUmc 12